Synthesis, in vitro Antitrichomonal Activity, and Docking Study of N-[(4-substituted phenyl)-1,3-thiazol-2-yl]-4-substituted Benzenesulfonamides

Authors

  • Rubén M. Carballo
  • Héctor A. Peniche-Pavía
  • Ramiro Quijano-Quiñones
  • David Cáceres-Castillo
  • Gumersindo Mirón-López
  • Manlio Graniel-Sabido
  • Andrea Reyes-Cuapio
  • Rosa E. Moo-Puc
  • Lía Valencia-Chan
  • Gonzalo Joaquín Mena-Rejón

DOI:

https://doi.org/10.29356/jmcs.v68i1.1975

Keywords:

Phenylthiazolyl benzenesulfonamide, Phenylthiazole, Benzenesulfonamide, Trichomonas vaginalis, Trichomoniasis, Docking studies, Trichomonas vaginalis ferredoxin

Abstract

Infection by Trichomonas vaginalis has a high incidence/prevalence worldwide. It has been associated with a predisposition to cervical neoplasia or prostate cancer and an increased risk of acquisition of human papillomavirus (HPV) and human immunodeficiency virus (HIV). Besides, resistance to the drugs used for trichomoniasis treatment has increased in the last 30 years. Herein, thirteen phenylthiazolylbenzene sulfonamides were synthesized and evaluated for their in vitro activity against Trichomonas vaginalis. Among them, four derivatives showed higher anti-trichomonal activity than metronidazole (IC50 = 0.93 µM), while their cytotoxicity levels were not significant. These compounds were subject to molecular docking studies using Trichomonas vaginalis ferredoxin as target. The results revealed that the orientation of the nitro group of the active derivatives is toward [2Fe-2S], the cluster responsible for high reactive oxygen species generation. Finally, it was evident that the presence of a nitro group in the structure of the synthesized phenylthiazolylbenzene sulfonamides is essential for their trichomonicidal activity.

 

Resumen. A nivel mundial la infección por Trichomonas vaginalis tiene una alta incidencia/prevalencia y se ha asociado con una predisposición a padecer neoplasia cervical o cáncer de próstata, así como a generar un mayor riesgo de adquirir el virus del papiloma humano (VPH) y el virus de la inmunodeficiencia humana (VIH). Además, en los últimos 30 años, la resistencia a los fármacos utilizados para el tratamiento de la tricomoniasis ha aumentado. En el presente trabajo, trece sulfonamidas de feniltiazolilbenceno fueron sintetizadas y evaluadas in vitro contra Trichomonas vaginalis. Cuatro de ellas exhibieron una actividad anti-tricomonas mayor que el metronidazol (CI50 = 0.93 µM), a la vez que citotoxicidad no significativa. Por tal motivo, estos compuestos fueron sometidos a estudios de acoplamiento molecular utilizando como diana a la ferredoxina de T. vaginalis. Los resultados revelaron que la orientación del grupo nitro de los derivados activos está dirigida hacia el grupo [2Fe-2S], responsable de la generación de especies de oxígeno altamente reactivas. Finalmente, se evidenció que la presencia de al menos un grupo nitro en la estructura de las sulfonamidas de feniltiazolilbenceno sintetizadas es esencial para su actividad tricomonicida.

Downloads

Download data is not yet available.

References

Capela, R.; Moreira, R.; Lopes, F. Int. J. Mol. Sci. 2019, 20, 5748. DOI: https://doi.org/10.3390/ijms20225748. DOI: https://doi.org/10.3390/ijms20225748

Garrido-Cardenas, J.A.; Mesa-Valle, C.; Manzano-Agugliaro F. Parasitology. 2018, 145, 699-712. DOI: https://doi.org/10.1017/S0031182017001718. DOI: https://doi.org/10.1017/S0031182017001718

Rowley J.; Vander Hoorn, S.; Korenromp, E.; Low, N.; Unemo, M.; Abu-Raddad, L.J.; Chico, R.M.; Smolak, A.; Newman, L.; Gottlieb, S.; Thwin, S.S.; Broutet, N.; Taylor, M.M. Bull. World Health Organ. 2019, 97, 548-562. DOI: https://doi.org/10.2471/BLT.18.228486. DOI: https://doi.org/10.2471/BLT.18.228486

Margarita, V.; Fiori, P.L.; Rappelli, P. Front. Cell. Infect. Microbiol. 2020, 10, 179. DOI: https://doi.org/10.3389/fcimb.2020.00179. DOI: https://doi.org/10.3389/fcimb.2020.00179

Stark, J.R.; Judson, G.; Alderete, J.F.; Mundodi, V.; Kucknoor, A.S.; Giovannucci, E.L.; Platz, E.A.; Sutcliffe, S.; Fall, K.; Kurth, T.; Ma, J.; Stampfer, M.J.; Mucci, L.A. J. Natl. Cancer Inst. 2009, 101, 1406-1411. DOI: https://doi.org/10.1093/jnci/djp306. DOI: https://doi.org/10.1093/jnci/djp306

Pasupuleti, V.; Escobedo, A.A.; Deshpande, A.; Thota, P.; Roman, Y.; Hernandez, A.V. PLoS Negl. Trop. Dis. 2014, 8, e2733.DOI: https://doi.org/10.1371/journal.pntd.0002733. DOI: https://doi.org/10.1371/journal.pntd.0002733

Grossman III, J.H.; Galask, R.P. Obstet. Gynecol. 1990, 76, 521-522. PMID: 2381638.

Bala, V.; Chhonker, Y.S. Eur. J. Med. Chem. 2018, 143, 232-243. DOI: https://doi.org/10.1016/j.ejmech.2017.11.029. DOI: https://doi.org/10.1016/j.ejmech.2017.11.029

Borcea, A.M.; Ionut, I.; Crisan, O.; Oniga, O. Molecules. 2021, 26, 624. DOI: https://doi.org/10.3390/molecules26030624. DOI: https://doi.org/10.3390/molecules26030624

Mocelo-Castell, R.; Villanueva-Novelo, C.; Caceres-Castillo, D.; Carballo, R.M.; Quijano-Quinones, R.F.; Quesadas-Rojas, M.; Cantillo-Ciau, Z.; Cedillo-Rivera, R.; Moo-Puc, R.E.; Moujir, L.M.; Mena-Rejon, G. J. Open Chem. 2015, 13, 1127-1136. DOI: https://doi.org/10.1515/chem-2015-0127. DOI: https://doi.org/10.1515/chem-2015-0127

Mena-Rejón, G.; Pérez-Navarro, Y.; Torres-Romero, J.C.; Vázquez-Carrillo, L.; Carballo, R.M.; Arreola, R.; Herrera-España, A.; Arana-Argáez, V.; Quijano-Quiñones, R.; Fernández-Sánchez, J.M.; Alvarez-Sánchez, M.E. Parasitol. Res. 2021, 120, 233-241. DOI: https://doi.org/10.1007/s00436-020-06931-w. DOI: https://doi.org/10.1007/s00436-020-06931-w

Apaydın, S.; Török, M. Bioorg. Med. Chem. Lett. 2019, 29, 2042-2050. DOI: https://doi.org/10.1016/j.bmcl.2019.06.041. DOI: https://doi.org/10.1016/j.bmcl.2019.06.041

Malagoli, M.; Rossi, T.; Baggio, A.; Zandomeneghi, G.; Zanca, A.; Casolari, C.; Castelli, M. Pharmacol. Res. 2002, 46, 469-472. DOI: https://doi.org/10.1080/14756366.2020.1863958. DOI: https://doi.org/10.1080/14756366.2020.1863958

Hernández-Núñez, E.; Tlahuext, H.; Moo-Puc, R.; Torres-Gómez, H.; Reyes-Martínez, R.; Cedillo-Rivera, R.; Nava-Zuazo, C.; Navarrete-Vazquez, G. Eur. J. Med. Chem. 2009, 44, 2975-2984. DOI: https://doi.org/10.1016/j.ejmech.2009.01.005. DOI: https://doi.org/10.1016/j.ejmech.2009.01.005

Cedillo-Rivera, R.; Chávez, B.; González-Robles, A.; Tapia-Contreras, A.; Yépez-Mulia, L. J. Euk. Microbiol. 2002, 49, 201-208. DOI: https://doi.org/10.1111/j.1550-7408.2002.tb00523.x. DOI: https://doi.org/10.1111/j.1550-7408.2002.tb00523.x

Rahman, A.; Choudhary, M.I.; Thomsen, W.J. Bioassay techniques for drug development. In: Manual of bioassay techniques for natural products research. Harwood Academic Publishers Netherlands, 2001. ISBN: 0-203-34349-2.

Lee, C.; Yang, W.; Parr, R.G. Phys. Rev. B. 1988, 37, 785-789. DOI: https://doi.org/10.1103/physrevb.37.785. DOI: https://doi.org/10.1103/PhysRevB.37.785

Spartan´20 Wavefunction, Inc., Irvine, CA.

Berman, H.M.; Westbrook, J.; Feng, Z.; Gilliland, G.; Bhat, T.N.; Weissig, H.; Shindyalov, I.N.; Bourne, P.E. Nucleic. Acids Res. 2000, 28, 235-242. DOI: https://doi.org/10.1093/nar/28.1.235. DOI: https://doi.org/10.1093/nar/28.1.235

Morris, G. M.; Huey, R.; Lindstrom, W.; Sanner, M.F.; Belew, R.K.; Goodsell, D.S.; Olson, A.J. J. Comput. Chem. 2009, 30. 2785-2791. DOI: https://doi.org/10.1002/jcc.21256. DOI: https://doi.org/10.1002/jcc.21256

Maestro, Schrödinger, LLC, New York, NY, 2019.

Caceres-Castillo, D.; Carballo, R.M.; Tzec-Interian, J.A.; Mena-Rejon, G. J. Tetrahedron Lett. 2012, 53, 3934-3936. DOI: https://doi.org/10.1016/j.tetlet.2012.05.093. DOI: https://doi.org/10.1016/j.tetlet.2012.05.093

Carballo, R.M.; Padilla-Montano, N.; Reyes-Martinez, R.; Miron-Lopez G.; Hernandez-Ortega, S. Acta Crystallogr., Sect. E: Struct. Rep. Online. 2014, 70, o6-7. DOI: https://doi.org/10.1107/S1600536814002086. DOI: https://doi.org/10.1107/S1600536813032145

Greenfield, A.; Grosanu, C. Tetrahedron Lett. 2008, 43, 6300-6303. DOI: https://doi.org/10.1016/j.tetlet.2008.08.054. DOI: https://doi.org/10.1016/j.tetlet.2008.08.054

Röver, S.; Cesura, A.M.; Huguenin, P.; Kettler, R.; Szente, A. J. Med. Chem. 1997, 40, 4378-4385. DOI: https://doi.org/10.1021/jm970467t. DOI: https://doi.org/10.1021/jm970467t

Hitchin, J.R.; Blagg, J.; Burke, R.; Burns, S.; Cockerill, M.J., Fairweather, E.E.; Hutton, C.; Jordan, A.M.; McAndrew, C.; Mirza, A.; Mould, D.; Thomson, G.J.; Waddella, I.; Ogilviea, D.J. MedChemComm. 2013, 4, 1513-1522. DOI: https://doi.org/10.1039/C3MD00226H. DOI: https://doi.org/10.1039/c3md00226h

Keseru, G.M.; Makara, G.M. Drug Discov. Today. 2006, 11, 741-748. DOI: https://doi.org/10.1016/j.drudis.2006.06.016. DOI: https://doi.org/10.1016/j.drudis.2006.06.016

Cos, P.; Vlietinck, A.J.; Berghe, D.V.; Maes, L. J. Ethnopharmacol. 2006, 106, 290-302. DOI: https://doi.org/10.1016/j.jep.2006.04.003. DOI: https://doi.org/10.1016/j.jep.2006.04.003

Pink, R.; Hudson, A.; Mouri`es, M.-A; Bendig, M. Nat. Rev. Drug Discov. 2005, 4, 727-740. DOI: https://doi.org/10.1038/nrd1824. DOI: https://doi.org/10.1038/nrd1824

Čėnas, N.; Nemeikaitė-Čėnienė, A.; Kosychova, L. Int. J. Mol. Sci. 2021, 22, 8534. DOI: https://doi.org/10.3390/ijms22168534. DOI: https://doi.org/10.3390/ijms22168534

Crossnoe, C.R.; Germanas, J.P.; LeMagueres, P.; Mustata, G.; Krause, K.L. J. Mol. Biol. 2002, 318, 503-18. DOI: https://doi.org/10.1016/S0022-2836(02)00051-7. DOI: https://doi.org/10.1016/S0022-2836(02)00051-7

Weksberg, T.E.; Lynch, G.C.; Krause, K.L.; Pettitt, B.M. Biophys. J. 2007, 92, 3337-3345. DOI: https://doi.org/10.1529/biophysj.106.088096. DOI: https://doi.org/10.1529/biophysj.106.088096

×

Downloads

Additional Files

Published

2024-01-01

Issue

Section

Special Issue dedicated to Prof. Joaquín Tamariz
x

Most read articles by the same author(s)

Similar Articles

<< < 5 6 7 8 9 10 11 12 13 14 > >> 

You may also start an advanced similarity search for this article.

Loading...